Health News
Forteo Approved for Drug-Related Osteoporosis
7/24/2009
Print E-mail
FRIDAY, July 24 (HealthDay News) -- Eli Lilly's Forteo (teriparatide injection) has received expanded approval from the U.S. Food and Drug Administration to treat osteoporosis associated with long-term use of glucocorticoid medication, the company said Thursday.
Glucocorticoid therapy is commonly prescribed for inflammatory conditions including rheumatoid arthritis and obstructive lung disease. These drugs are among the most common causes of secondary osteoporosis, which increases users' risk of bone fracture, Lilly said in a news release. continue reading http://www.everydayhealth.com/publicsite/news/view.aspx?id=629360
Verlia Caldwell, MA
www.icareforyouhomecare.com
(800)383-0520
No comments:
Post a Comment